First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors

Published:2013-12-13 Issue:12 Volume:8 Page:e83232
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mross Klaus,Richly Heike,Fischer Richard,Scharr Dirk,Büchert Martin,Stern Angelika,Gille Hendrik,Audoly Laurent P.,Scheulen Max E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis;D Hanahan;Cell,1996

2. Vascular endothelial growth factor: basic science and clinical progress;N Ferrara;Endocr Rev,2004

3. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis;DJ Hicklin;J Clin Oncol,2005

4. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease;DI Holmes;Genome Biol,2005

5. VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy;N Rahimi;Front Biosci,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of regulation of hepcidin and ferroportin in cancer patients (literary review);Russian Journal of Biotherapy;2023-10-17

2. β‐Lactoglobulin variants as potential carriers of pramoxine: Comprehensive structural and biophysical studies;Journal of Molecular Recognition;2023-08-23

3. The Potential Impact of New Drug and Therapeutic Modalities on Drug Resistance to Renal Cell Carcinoma;Anticancer Research;2023-02-28

4. Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality;Antibodies;2022-08-22

5. Artificial Scaffold PolypeptidesAs an Efficient Tool for the Targeted Delivery of Nanostructures In Vitro and In Vivo;Acta Naturae;2022-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3